Dr. Horng is board-certified in critical care medicine, internal medicine, and
pulmonary disease, and he specializes in the evaluation and diagnosis of pulmonary
nodules and masses. He has co-authored clinical research papers on predicting tumor
response to therapy after oncogene inactivation; progressive dyspnea after CABG; tumorigenesis
in lung adenocarcinomas; and multidrug resistance in cancer cells. Past honors for
Dr. Horng include a Teacher of the Year Award for CPMC’s Internal Medicine Residency
Program and an American Thoracic Society Fellows Career Development Award. He was
Resident of the Year at the University of California, Los Angeles/Greater Los Angeles
VA Medical Center Internal Medicine Training Program.
Sutter Health Research Enterprise
2351 Clay Street Suite 501
San Francisco, CA, 94115
(415) 923-3421
horngg@sutterhealth.org
Primary Research Interests
Related Clinical Trials
APELLIS
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Investigators: Jey Chung MD, Ryan Dougherty M.D., George Horng M.D.
Status: Active, Recruiting
iLuekPulm (Coming Soon)
Study of Sargramostim in Patients With COVID-19 (iLeukPulm)
Investigators: Ryan Dougherty M.D., George Horng M.D.